The city of Irvine, California, currently has 97 active clinical trials seeking participants for Cancer research studies.
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Recruiting
The standard of care imaging of prostate cancer metastases recommended by the National Comprehensive Cancer Network (NCCN), CT of the chest/abdomen/pelvis and bone scan, may be suboptimal. PyL is a novel PET tracer designed to detect prostate specific membrane antigen (PSMA) expressed on prostate cancer cells. PyL PET/CT may provide improved evaluation of clinically significant metastases in patients with prostate cancer.
Gender:
MALE
Ages:
18 years and above
Trial Updated:
07/26/2021
Locations: Hoag Memorial Hospital Presbyterian, Irvine, California
Conditions: Prostate Cancer